与癌症相关的脱发风险和治疗方法
Lily Kaufman1, Lilia Valentic1, Hannah Moulton1
1The Ohio State University College of Medicine, Columbus, OH, USA.
Current treatment options in oncology
|July 14, 2025
概括
管理与癌症相关的脱发症 (CRA) 涉及积极的策略,如为化疗患者的头皮冷却,以防止脱发. 建议局部使用米诺克西迪尔来促进头发的再生,在特定情况下还有其他可用的选择.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 患者护理 患者护理
背景情况:
- 与癌症相关的脱发症 (CRA) 显著影响患者的生活质量和身份.
- 对CRA有效的管理策略对于癌症治疗期间的患者福祉至关重要.
研究的目的:
- 概述一种最佳的,个性化的方法来管理与癌症相关的脱发症.
- 审查基于证据的策略,以预防和促进癌症患者的头发再生.
主要方法:
- 关于当前CRA管理实践的文献审查和专家意见.
- 评估预防措施,如头皮冷却.
- 评估药理和非药理治疗的头发再生.
主要成果:
- 推头皮冷却作为化疗引起的脱发的第一线预防方案.
- 局部用米诺克西迪尔是促进头发再生的最有证据的药理疗法.
- 由于证据有限,其他治疗方法,如螺旋,特里诺因和红光疗法,可能需要谨慎考虑.
结论:
- 积极主动,以患者为中心和多学科的方法对于最佳的CRA管理至关重要.
- 整合针对个体患者需求和癌症治疗的预防和再生策略是关键.
- 对于在瘤学环境中使用口服氧化等新兴治疗方法,需要继续进行研究.
关键词:
与癌症相关的脱发症与癌症相关的脱发症化疗引起的脱发是由于化疗引起的.内分泌疗法诱导的脱发是内分泌疗法引起的.头发再生的治疗方法 头发再生的治疗方法头皮冷却疗法是一种头皮冷却疗法.支持性瘤治疗护理更多相关视频
03:22Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia
Published on: January 27, 2018
15.2K
06:08Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
1.9K
相关概念视频
Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456
Skin Cancer
4.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.6K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
